Catalyst Wire Dossier Catalyst Wire Dossier

rDEN4delta30-200,201 dengue vaccine candidate

Dengue virus vaccine (rDEN4Δ30-200,201) · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rDEN4delta30-200,201 dengue vaccine candidate, covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults [Phase 1]

See pricing